Achilles Therapeutics PLC is a clinical-stage biopharmaceutical company that focuses on the development of personalized immunotherapies for cancer treatment. The company’s proprietary technology aims to identify and target tumor-specific mutations, potentially revolutionizing the way cancer is treated. With promising results in preclinical and early-stage clinical trials, Achilles Therapeutics shows great potential in the fight against cancer.
